Search details
1.
Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAFV600E mutated, microsatellite-stable colon cancer: A case report and literature review.
Front Oncol
; 13: 1166545, 2023.
Article
in English
| MEDLINE | ID: mdl-37213293
2.
REGO-ACT: assessment of physical activity during treatment with regorafenib for metastatic colorectal cancer.
Wien Klin Wochenschr
; 132(15-16): 423-430, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32643016
3.
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Anticancer Res
; 37(10): 5553-5558, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28982869
Results
1 -
3
de 3
1
Next >
>>